Budesonide CRL Another Setback For Takeda’s ‘Wave 1’ Pipeline

 
• By Ian Haydock

Setback for company's near-term launch goals and US patients with rare esophageal inflammatory condition as regulator asks for additional clinical data. 

esophagitis
US FDA Decides Not To Approve First Drug For Eosinophilic Esophagitis • Source: Alamy

More from New Products

More from Scrip